Senescent alveolar macrophages promote early-stage lung tumorigenesis

Cancer Cell. 2023 Jul 10;41(7):1261-1275.e6. doi: 10.1016/j.ccell.2023.05.006. Epub 2023 Jun 1.

Abstract

Senescent cells play relevant but context-dependent roles during tumorigenesis. Here, in an oncogenic Kras-driven lung cancer mouse model, we found that senescent cells, specifically alveolar macrophages, accumulate early in neoplasia. These macrophages have upregulated expression of p16INK4a and Cxcr1, are distinct from previously defined subsets and are sensitive to senolytic interventions, and suppress cytotoxic T cell responses. Their removal attenuates adenoma development and progression in mice, indicating their tumorigenesis-promoting role. Importantly, we found that alveolar macrophages with these properties increase with normal aging in mouse lung and in human lung adenocarcinoma in situ. Collectively, our study indicates that a subset of tissue-resident macrophages can support neoplastic transformation through altering their local microenvironment, suggesting that therapeutic interventions targeting senescent macrophages may attenuate lung cancer progression during early stages of disease.

Keywords: aging; alveolar macrophages; cellular senescence; cytotoxic T cells; senolytic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Cellular Senescence
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Humans
  • Lung / metabolism
  • Lung Neoplasms* / genetics
  • Macrophages, Alveolar* / metabolism
  • Mice
  • Tumor Microenvironment

Substances

  • Cyclin-Dependent Kinase Inhibitor p16